{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T11:56:28Z","timestamp":1784289388567,"version":"3.55.0"},"reference-count":99,"publisher":"Informa UK Limited","issue":"9","funder":[{"name":"no funding"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Anticancer Therapy"],"published-print":{"date-parts":[[2021,9,2]]},"DOI":"10.1080\/14737140.2021.1918548","type":"journal-article","created":{"date-parts":[[2021,4,17]],"date-time":"2021-04-17T01:59:33Z","timestamp":1618624773000},"page":"1003-1016","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":13,"title":["Immune checkpoint inhibition in classical hodgkin lymphoma"],"prefix":"10.1080","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2817-4734","authenticated-orcid":false,"given":"Parmida Sadat","family":"Pezeshki","sequence":"first","affiliation":[{"name":"School of Medicine, Tehran University of Medical Sciences, Tehran, Iran"},{"name":"Cancer Immunology Project (CIP), Universal Scientific Education and Research Network (USERN), Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahsa","family":"Eskian","sequence":"additional","affiliation":[{"name":"Neuroimaging Network (NIN), Universal Scientific Education and Research Network (USERN), Tehran, Iran"},{"name":"Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children\u2019s Medical Center, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R","family":"Hamblin","sequence":"additional","affiliation":[{"name":"Neuroimaging Network (NIN), Universal Scientific Education and Research Network (USERN), Tehran, Iran"},{"name":"Laser Research Centre, Faculty of Health Science, University of Johannesburg, Doornfontein South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nima","family":"Rezaei","sequence":"additional","affiliation":[{"name":"Cancer Immunology Project (CIP), Universal Scientific Education and Research Network (USERN), Tehran, Iran"},{"name":"Neuroimaging Network (NIN), Universal Scientific Education and Research Network (USERN), Tehran, Iran"},{"name":"Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children\u2019s Medical Center, Tehran University of Medical Sciences, Tehran, Iran"},{"name":"Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran"},{"name":"Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,4,27]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21551"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25071"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2016.05.010"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2016.205"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1038\/nm730"},{"issue":"8","key":"cit0006","first-page":"711","volume":"363","author":"Fs H","journal-title":"N Engl J Med"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-05-282780"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.16.1.471"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(01)00105-8"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-05-085159"},{"issue":"3","key":"cit0011","first-page":"220","volume":"36","author":"Harris NL","journal-title":"Semin Hematol"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.23119"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V88.9.3299.bloodjournal8893299"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.32.8401"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-06-508044"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0010865"},{"issue":"5","key":"cit0017","first-page":"1764","volume":"12","author":"Shan T","year":"2019","journal-title":"Int J Clin Exp Pathol"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.77.3994"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.66.4482"},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2007.04.012"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-0855"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-07-796342"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15253"},{"key":"cit0024","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1995.tb05367.x"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.5732\/cjc.014.10122"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.1016\/0952-7915(95)80077-8"},{"issue":"3","key":"cit0027","first-page":"199","volume":"20","author":"Callahan GN","year":"1996","journal-title":"Cancer Detect Prev"},{"key":"cit0028","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.8.3539"},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.7235"},{"key":"cit0030","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.21775"},{"key":"cit0031","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12030738"},{"key":"cit0032","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0802769"},{"key":"cit0033","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.67.3467"},{"key":"cit0034","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1411087"},{"key":"cit0035","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30167-X"},{"key":"cit0036","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V92.7.2477"},{"key":"cit0037","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020008553"},{"key":"cit0038","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-1006-1"},{"key":"cit0039","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2018.06.001"},{"key":"cit0040","doi-asserted-by":"publisher","DOI":"10.1111\/cas.13230"},{"key":"cit0041","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw169"},{"key":"cit0042","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-1387"},{"key":"cit0043","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.76.0793"},{"key":"cit0044","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2011.644547"},{"key":"cit0045","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-11-749556"},{"key":"cit0046","unstructured":"Dada RA-O, Usman B Allogeneic hematopoietic stem cell transplantation in r\/r Hodgkin lymphoma after treatment with checkpoint inhibitors: feasibility and safety. (1600-0609 (Electronic))."},{"key":"cit0047","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-125039"},{"key":"cit0048","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-017-0705-5"},{"key":"cit0049","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2437_72"},{"key":"cit0050","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.38.0410"},{"key":"cit0051","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-10-811224"},{"key":"cit0052","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199001043220102"},{"key":"cit0053","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-122576"},{"key":"cit0054","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-123162"},{"key":"cit0055","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.00315"},{"key":"cit0056","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2020.0750"},{"key":"cit0057","unstructured":"Herrera AF 2969 SWOG S1826: a phase III, randomized study of nivolumab plus AVD or brentuximab vedotin plus AVD in patients with newly diagnosed advanced stage classical hodgkin lymphoma. Session: 624. Hodgkin lymphoma and T\/NK cell lymphoma\u2014clinical studies: Poster III. Poster session presented at: the 62nd ASH annual meeting and exposition, 2020 Dec 5; CA: San Diego."},{"key":"cit0058","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30023-1"},{"key":"cit0059","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-99-111279"},{"key":"cit0060","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-124866"},{"key":"cit0061","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-99-111812"},{"issue":"1","key":"cit0062","first-page":"82","volume":"37","author":"Longley J","journal-title":"Hematol Oncol"},{"key":"cit0063","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019001367"},{"key":"cit0064","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019000215"},{"key":"cit0065","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-142565"},{"key":"cit0066","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.72.1316"},{"key":"cit0067","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019000324"},{"key":"cit0068","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-123163"},{"key":"cit0069","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019004701"},{"key":"cit0070","unstructured":"Moskowitz AJ Phase II study of pembrolizumab plus GVD as second-line therapy for relapsed or refractory classical hodgkin lymphoma. Session: 624. Hodgkin lymphoma and T\/NK cell lymphoma\u2014clinical studies: clinical studies in Hodgkin lymphoma. Paper presented at: the 62nd ASH annual meeting and exposition, 2020 Dec 5; CA: San Diego."},{"key":"cit0071","author":"Allen PB","journal-title":"Blood"},{"key":"cit0072","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2019.1654303"},{"key":"cit0073","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(18)30192-3"},{"key":"cit0074","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-018-2160-x"},{"key":"cit0075","unstructured":"Song Y, Gao Q, Zhang H. Treatment of relapsed or refractory classical Hodgkin lymphoma with the anti-PD-1, tislelizumab: results of a phase 2, single-arm, multicenter study. (1476-5551 (Electronic))."},{"key":"cit0076","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-020-01286-z"},{"key":"cit0077","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-1680"},{"key":"cit0078","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.02151"},{"issue":"2","key":"cit0079","first-page":"67","volume":"35","author":"Chen R","journal-title":"Hematol Oncol"},{"key":"cit0080","doi-asserted-by":"publisher","DOI":"10.1016\/1074-7613(95)90125-6"},{"key":"cit0081","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.17.10067"},{"key":"cit0082","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-07-168468"},{"key":"cit0083","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-17-0673"},{"key":"cit0084","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(20)30221-0"},{"key":"cit0085","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9113483"},{"key":"cit0086","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.54.8800"},{"key":"cit0087","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2020192056"},{"key":"cit0088","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-16-1223"},{"key":"cit0089","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-17-1033"},{"key":"cit0090","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.2168"},{"key":"cit0091","doi-asserted-by":"publisher","DOI":"10.1016\/j.semradonc.2014.07.004"},{"key":"cit0092","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2016.06.017"},{"key":"cit0093","unstructured":"NCT04419441. [cited 2020 Jun 5]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/results\/NCT04419441?term=nivolumab&cond=Classical+Hodgkin+Lymphoma&draw=3&rank=24"},{"key":"cit0094","unstructured":"NCT03480334. [cited 2018 Mar 29]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03480334?term=nivolumab&cond=Classical+Hodgkin+Lymphoma&draw=2&rank=5"},{"key":"cit0095","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2010.223"},{"key":"cit0096","unstructured":"Maleki Vareki S, Garrig\u00f3s C, Duran I Biomarkers of response to PD-1\/PD-L1 inhibition. (1879-0461 (Electronic))."},{"key":"cit0097","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.102731"},{"key":"cit0098","unstructured":"Oweida A, Hararah MK, Phan A. Resistance to radiotherapy and PD-L1 blockade is mediated by TIM-3 upregulation and regulatory T-cell infiltration. (1078-0432 (Print))."},{"key":"cit0099","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.30642"}],"container-title":["Expert Review of Anticancer Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14737140.2021.1918548","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T18:19:28Z","timestamp":1630433968000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14737140.2021.1918548"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,27]]},"references-count":99,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9,2]]}},"alternative-id":["10.1080\/14737140.2021.1918548"],"URL":"https:\/\/doi.org\/10.1080\/14737140.2021.1918548","relation":{},"ISSN":["1473-7140","1744-8328"],"issn-type":[{"value":"1473-7140","type":"print"},{"value":"1744-8328","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,27]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iery20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iery20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-12-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-06","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}